Elicera Therapeutics (Sweden) Insiders
| ELIC Stock | 1.89 0.15 8.62% |
Elicera Therapeutics employs about 1 people. The company is managed by 4 executives with a total tenure of roughly 3 years, averaging almost 0.0 years of service per executive, having 0.25 employees per reported executive. Breaking down Elicera Therapeutics' management performance can provide insight into the firm performance.
| Jamal MSc Insider CEO CoFounder |
| Pr Essand Insider CoFounder Officer |
Elicera |
Elicera Therapeutics Management Team Effectiveness
The company has return on total asset (ROA) of (0.2258) % which means that it has lost $0.2258 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3883) %, meaning that it generated substantial loss on money invested by shareholders. Elicera Therapeutics' management efficiency ratios could be used to measure how well Elicera Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities.Elicera Therapeutics Workforce Comparison
Elicera Therapeutics AB is rated # 4 in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 41.0. Elicera Therapeutics holds roughly 1.0 in number of employees claiming about 2.44% of stocks in Biotechnology industry.
Elicera Therapeutics Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Elicera Therapeutics Price Series Summation is a cross summation of Elicera Therapeutics price series and its benchmark/peer.
Elicera Therapeutics Notable Stakeholders
An Elicera Therapeutics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Elicera Therapeutics often face trade-offs trying to please all of them. Elicera Therapeutics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Elicera Therapeutics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Jamal MSc | CEO CoFounder | Profile | |
| Pr Essand | CoFounder Officer | Profile | |
| Di Yu | CoFounder Operations | Profile | |
| Ingvar Karlsson | Chief Officer | Profile |
About Elicera Therapeutics Management Performance
The success or failure of an entity such as Elicera Therapeutics often depends on how effective the management is. Elicera Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Elicera management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Elicera management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the imprecision that can be found in Elicera Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Elicera Therapeutics AB. Check Elicera Therapeutics' Beneish M Score to see the likelihood of Elicera Therapeutics' management manipulating its earnings.
Elicera Therapeutics Workforce Analysis
Traditionally, organizations such as Elicera Therapeutics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Elicera Therapeutics within its industry.Elicera Therapeutics Manpower Efficiency
Return on Elicera Therapeutics Manpower
| Revenue Per Employee | 587 | |
| Revenue Per Executive | 147 | |
| Net Loss Per Employee | 13.1M | |
| Net Loss Per Executive | 3.3M |
Additional Tools for Elicera Stock Analysis
When running Elicera Therapeutics' price analysis, check to measure Elicera Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elicera Therapeutics is operating at the current time. Most of Elicera Therapeutics' value examination focuses on studying past and present price action to predict the probability of Elicera Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elicera Therapeutics' price. Additionally, you may evaluate how the addition of Elicera Therapeutics to your portfolios can decrease your overall portfolio volatility.